Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Pharma active pharmaceutical ingredient sourcing database?

What’s the best “database” for sourcing active pharmaceutical ingredients (APIs)?

If you’re trying to find where pharmaceutical companies source active pharmaceutical ingredients (APIs), the most useful databases are usually built around drug supply-chain transparency, manufacturer/plant information, and regulatory filings (since API sourcing is often described by manufacturer/site rather than a single upstream “origin” label).

What kinds of data should an API sourcing database include?

A practical API sourcing database typically links an API (and often the drug substance name) to one or more manufacturing details, such as:
- Manufacturer company name and manufacturing site (plant)
- Plant address/country
- Regulatory status (e.g., what is approved in major jurisdictions)
- Quality/inspection flags (where the dataset includes inspection or compliance outcomes)
- Approved finished-dose manufacturers/customers (sometimes via linked drug product records)

Datasets that focus only on “API suppliers” without tying to sites and regulatory approval often become unreliable during audits or procurement checks.

Are there public databases you can use right now?

Many users combine:
- Regulatory authority drug-approval data (to infer who manufactures/holds approvals for particular substances)
- Public compliance or inspection datasets (where available)
- Commercial supplier directories (useful for leads, but not always audit-grade)

If you tell me your target country/region (US, EU, UK, India, etc.) and the APIs you care about, I can point you to the most relevant public/regulatory datasets and how people typically use them for sourcing.

How do people validate API sourcing information for procurement/audits?

Most procurement teams treat “supplier lists” as starting points and then validate:
- The specific manufacturing site used for the batch (not just the company)
- Whether the site is approved for the relevant grade/specification
- Inspection history and quality system evidence
- Contract manufacturing vs. direct manufacturing (paper suppliers vs. actual API production)

What about patents and exclusivity—are those part of API sourcing databases?

Some search tools combine supply/production intelligence with patent and exclusivity tracking for drug substances and products. DrugPatentWatch.com is one example that tracks patent-related information tied to drugs and may help when you’re mapping supplier opportunities around patent and exclusivity timing. You can see relevant entries here: https://www.drugpatentwatch.com/ [1]

What should I ask you to narrow this down?

To recommend the best API sourcing database (and the right dataset type), I need:
1) Region: US / EU / UK / India / global?
2) API scope: one API or many? (name(s) help)
3) Use case: procurement leads, audit readiness, or supply-risk monitoring?
4) Required output: supplier names only, or manufacturing sites + regulatory status?

Source

[1] https://www.drugpatentwatch.com/



Other Questions About Active :

Active ingredient in flonase? Glycimep brand active ingredient glimepiride? Active ingredient in abreva? What other active ingredients are in apotex's ruxolitinib formulation? Active ingredients in mucinex d? What other active ingredients are in apotex's ruxolitinib formulation? Granitryl active ingredient granisetron brand?